In this randomized controlled trial of 197 cutaneous Leishmaniasis (cl) patients reported from Qom health centers in 2016,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: diagnosis of leishmaniasis based on the observation leishman bodies in smears from skin lesions, the onset of the disease should be less than 4 weeks ago, completion of epidemiologic survey forms and having age 10 years or older
Exclusion criteria
Exclusion criteria: taking any drugs; antibiotics or anti-Leishmania during the last 4 weeks, lactating and pregnant mothers, having large skin lesions with a diameter of 5 cm and ultimately the patients with lesions of more than three on their bodies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At first, the lesion size and induration of lesions were recorded. first centimeter | — |
Secondary
| Measure | Time frame |
|---|---|
| After 7 and 12 weeks of treatment, lesions healing rate was monitored. After 7 and 12 weeks of treatment lesions healing | — |
Countries
Iran
Contacts
Department of Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran